SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149304
Filing Date
2023-05-19
Accepted
2023-05-19 16:06:58
Documents
19
Period of Report
2023-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407449d8k.htm   iXBRL 8-K 35775
2 EX-1.1 d407449dex11.htm EX-1.1 170382
3 EX-4.1 d407449dex41.htm EX-4.1 69963
4 EX-5.1 d407449dex51.htm EX-5.1 15505
5 EX-99.1 d407449dex991.htm EX-99.1 9245
6 EX-99.2 d407449dex992.htm EX-99.2 9111
10 GRAPHIC g407449g0519104205937.jpg GRAPHIC 3436
11 GRAPHIC g407449g0519223842832.jpg GRAPHIC 4354
  Complete submission text file 0001193125-23-149304.txt   530001

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA prld-20230518.xsd EX-101.SCH 2845
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20230518_lab.xml EX-101.LAB 17979
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20230518_pre.xml EX-101.PRE 11255
13 EXTRACTED XBRL INSTANCE DOCUMENT d407449d8k_htm.xml XML 3399
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 23940076
SIC: 2834 Pharmaceutical Preparations